Scientists and researchers continue to work on new technologies and treatments for diabetes.
OMNIA is an artificial pancreas system that helps you stay in a safe glucose range and avoid complications associated with diabetes. It’s an app built with a neural network-powered algorithm. OMNIA has an easy configuration and setup process. It is currently available in Europe, parts of Asia, the Middle East, and the United States.
MySugr app offers carbohydrate counting, glucose tracking, and a bolus dose calculator. This app can send you reminders such as to check your blood glucose level after exercise and you can easily forward reports to your diabetes health professional.
Lumen is the world’s first hand-held, portable device to accurately measure metabolism. It measures the CO2 levels in your breath to interpret your metabolism by understanding if your body is using fats or carbs for fuel. Lumen will provide a daily personalized nutrition plan and insights on your sleep or workouts. By focusing on metabolism, instead of restrictive or unsustainable diets, Lumen helps you to lose weight and keep it off.
New GLP-1 medications target areas of the brain involved in regulating appetite and food intake. This can help you eat less, which helps lower blood glucose levels and can lead to weight loss.
Mounjaro (Tirzepatide) is a new weekly injection for the treatment of type 2 diabetes. It is a combination medication mimicking glucose-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 and GIP are hormones that are released by the cells in your gut whenever you eat. They cause the pancreas to release insulin. Mounjaro lowers blood glucose levels, assists in weight loss, and reduces the build-up of fat in your liver.
New medication: PATAS. A team of English, American, Australian, and French researchers found that insulin resistance is caused by the inability of fat cells to regulate glucose metabolism. A new medication that ‘reboots’ how your fat cells use insulin could revolutionize the treatment of type 2 diabetes. PATAS is being developed and could be delivered by injection or possibly a patch.
FixiC adhesive patches for Dexcom have already been developed. You can use them right now and feel the freedom to do your daily routine without worrying about your sensor!